A

AbbVie

Global biopharmaceutical company developing medicines

Senior Administrative Assistant - Global Business Platforms

Full-TimeUpdated on 10/23/2026
$27 - $48.80/hr+ Short-term incentive program
Mid, Senior
Bachelor's, Associate's
Mettawa, IL, USA
Hybrid
Administrative & Executive AssistanceExecutive Support

About the job

Requirements
  • A high school diploma is required.
  • A minimum of 3–5 years of administrative experience, including supporting senior or executive-level leaders at VP level or above, is required.
  • Exceptional communication and interpersonal skills are required, including the ability to build trust, listen, and manage competing expectations and demands across a diverse, matrixed stakeholder base.
  • Demonstrated experience planning and executing large-scale events with multiple external vendors is required.
  • Excellent attention to detail and organizational skills are required, including the ability to manage competing priorities under deadline pressure in a fast-paced, technology-driven environment.
  • The ability to work independently and collaboratively within a team environment is required.
  • Advanced proficiency in Microsoft Office Suite (Outlook, Word, PowerPoint, and Excel) and corporate travel and expense systems is required.
  • A proven track record of reliable execution and the ability to self-manage time and priorities are required.
  • Demonstrated resilience and composure in high-stress, fast-changing situations, with sound judgment under pressure, is required.
  • The candidate must be proactive and able to think, act, and communicate in advance.
Responsibilities
  • Manage and proactively prioritize the VP's calendar and, as needed, calendars for other senior leaders; anticipate and resolve scheduling conflicts across a heavily matrixed stakeholder base before they escalate.
  • Monitor and triage executive correspondence, including email and calls, from internal executive stakeholders, Business Unit IT leaders, and external technology vendors and partners; draft responses and flag priority actions.
  • Coordinate meeting logistics as needed, compile briefing and meeting materials, and prepare or revise presentations and business documents for governance reviews, portfolio updates, and executive stakeholder communications.
  • Book and coordinate complex domestic and international travel arrangements for the VP and other senior leaders.
  • Process related expense reports accurately and promptly, ensuring compliance with company travel policy.
  • Plan and execute large-scale organizational events, including Global Town Halls, leadership offsites, and all-hands meetings for an organization of more than 1,200 people; source vendors, manage contracts and budgets, coordinate on-site logistics, and complete post-event follow-up.
  • Own logistics for team-building and engagement activities, including summer picnics and holiday events, for a large, globally distributed team.
  • Facilitate departmental reviews, town halls, and cultural and social activities in partnership with organizational leaders and Business Unit IT partners.
  • Administer organizational SharePoint sites from a user-access perspective by managing permissions, onboarding and offboarding employees and non-employees, and maintaining site structure in accordance with governance policies.
  • Maintain departmental files and confidential or business-sensitive information, including budget, vendor contract, and organizational strategy materials, in compliance with corporate and legal guidelines.
  • Support office setup and onboarding for new employees and contractors.
  • Process financial transactions, including creating purchase orders, routing and paying invoices, and reconciling related records in compliance with company purchasing policies.
  • Manage procurement of office supplies and stationery, including inventory and vendor relationships.
  • Identify and flag cost-saving or process-efficiency opportunities in day-to-day office operations.
  • Serve as a trusted point of contact for the VP and leadership team, coordinating communication among Commercial Operations executives, Business Unit IT leaders, and cross-functional partners.
  • Build and maintain relationships with technology vendors, external partners, facilities, IT, and cross-functional teams to support event execution and operational needs.
Desired Qualifications
  • An associate's or bachelor's degree is a plus.
  • Experience supporting multiple leaders concurrently is preferred.
  • Experience with purchase order creation, invoice or accounts payable processing, or procurement systems such as SAP, Ariba, or Concur is strongly preferred.
  • Working knowledge of SharePoint administration, including site and user management, is preferred.
  • Familiarity with procurement processes and internal controls or governance standards is desirable.
  • Experience coordinating with facilities, catering, and event vendors is desirable.
  • Understanding of the pharmaceutical or biopharmaceutical business environment and/or exposure to a technology or IT organization is desirable.
  • Experience supporting leaders in large, global, matrixed organizations with diverse executive stakeholders is desirable.

About the company

AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.

Company Size

10,001+

Company Stage

IPO

Headquarters

North Chicago, Illinois

Founded

1888

Get referred to AbbVie

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
  • EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
  • JUVMO launches in October 2026, adding a fresh neuroscience revenue line.

What critics are saying

  • Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
  • Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
  • Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.

What makes AbbVie unique

  • Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
  • JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
  • AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Flexible Work Hours
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

4%

1 year growth

5%

2 year growth

5%
Yahoo Finance
Oct 24th, 2026
AbbVie wins FDA nod for at-home Skyrizi starts in Crohn's; sales boost seen after 60-90 days

AbbVie won US Food and Drug Administration (FDA) approval on October 23 for an at-home start to Skyrizi in adults with moderately to severely active Crohn's disease. Patients previously had to begin with intravenous infusions; they can now take the first doses at home with an on-body injector. By Week 12, 74% of patients new to advanced therapy reached clinical remission, against 27% on placebo. Johnson & Johnson's rival Tremfya won similar approval about 19 months earlier. Chief commercial officer Jeff Stewart said full paid access "will probably take 60 or 90 days" because insurers must approve the regimen. Sales impact should therefore come mostly after the fourth quarter. AbbVie reports third-quarter results on October 30. It guides for revenue of about $17.2 billion; Skyrizi's franchise sold $17.562 billion in 2025.

Yahoo Finance
Oct 23rd, 2026
ETFs net sell $42.1M of AbbVie as XLV leads $32.0M exit

Exchange-traded funds (ETFs) were net sellers of AbbVie shares for a second straight session, selling a net $42.1 million on October 21. Sellers moved larger sums even though more funds bought than sold: 24 ETFs added shares and 23 cut them. The Health Care Select Sector SPDR Fund led the selling with $32.0 million, followed by iShares Core S&P 500 ETF at $9.3 million and SPDR S&P 500 ETF Trust at $2.0 million. On October 20, ETFs sold a net $6.7 million, after three days of net buying. AbbVie has a market cap of $504.0 billion. Trailing 12-month revenue was $64.39 billion, up 10.3% over the past year.

Yahoo Finance
Oct 22nd, 2026
Abbott stock: $247,767 in shares yields $500 a month in dividends ahead of Q3 earnings

Abbott Laboratories will report third-quarter earnings before the market opens on Wednesday, October 21. Analysts expect earnings of $1.41 per share, up from $1.30 a year earlier, and revenue of $12.99 billion, against $11.37 billion last year. On October 16, TD Cowen analyst Joshua Jennings reiterated a Buy rating and a $135 price target. Abbott pays a quarterly dividend of 63 cents per share ($2.52 a year), a yield of 2.42%. To earn $500 a month ($6,000 a year) from dividends alone, an investor would need about 2,381 shares, or roughly $247,767.

Yahoo Finance
Oct 21st, 2026
Retirees swap Social Security for 5 dividend stocks yielding up to 6.64%

Retirees looking for income beyond Social Security are turning to dividend stocks. The 2027 cost-of-living adjustment is tracking toward 3.3%, and five companies from different industries were screened for dividend safety first, then yield. Verizon yields 6.64% and Altria 6.17%. Verizon's free cash flow guidance of $21.94 billion to $22.14 billion covers its roughly $11.76 billion annual dividend. Altria's payout is about 79% of the low end of its 2026 earnings guidance. Realty Income pays monthly at a 5.99% yield and has raised its dividend 115 consecutive quarters. Enbridge yields 5.95%. AbbVie yields 2.48%, but its quarterly dividend has grown from $0.40 in 2013 to $1.73 in 2026. Risks include satellite competition for Verizon, falling cigarette volumes for Altria, and currency swings for Enbridge.

Yahoo Finance
Oct 19th, 2026
Merck and AbbVie shares jump 39% and 24% in 2026 as dividend picks for a decade

Healthcare stocks are rebounding in 2026, led by Merck and AbbVie. Merck shares have climbed 39% and AbbVie's 24%, against about 12% for the S&P 500. Merck's second-quarter revenue rose 5% to $16.6 billion, beating Wall Street estimates. Keytruda sales hit $8.4 billion, though the drug will likely lose patent exclusivity by 2028. A subcutaneous version, Keytruda Qlex, may help retain market share. Merck's forward dividend yield is 2.3%. AbbVie's revenue grew 10.2% to almost $17 billion, with adjusted earnings per share up 22.9% to $3.65. Skyrizi and Rinvoq sales each rose about 24%, and neither faces US competition until 2033 and 2037 respectively. AbbVie has raised its dividend for 54 straight years, including its time as part of Abbott Laboratories.